International Early Lung Cancer Action Program (I-ELCAP)
Company

International Early Lung Cancer Action Program (I-ELCAP)

Hospitals And Health Care New York, Ny, United States 126 employees
Employees
126

International Early Lung Cancer Action Program (I-ELCAP) Overview

Headquarters
New York, Ny, United States
Website
www.ielcap.org
Industry
Hospitals And Health Care
Employees
126
NAICS
Health Care and Social Assistance
Social Assistance

About International Early Lung Cancer Action Program (I-ELCAP)

The International Early Lung Cancer Action Program (I-ELCAP) is an ongoing screening program that began accruing participants in 1994. It initially had two participating institutions, NYU and Cornell and now includes over 80 sites worldwide. The Principal Investigator for this program is Claudia Henschke PhD, MD, who is currently at Mount Sinai Hospital, which is the coordinating center for the program. I-ELCAP is the largest multi-center screening program in the world having already accrued over 80,000 participants and new sites continue to enroll. The program strives to be at the forefront of both innovation and clinical care, which has helped to set the standard in screening that has been adopted globally.

Compare Similar Companies to International Early Lung Cancer Action Program (I-ELCAP)